These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 26163998)
1. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Jasiewicz M; Knapp M; Waszkiewicz E; Ptaszynska-Kopczynska K; Szpakowicz A; Sobkowicz B; Musial WJ; Kaminski KA Cytokine; 2015 Dec; 76(2):187-192. PubMed ID: 26163998 [TBL] [Abstract][Full Text] [Related]
2. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling. Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission. Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616 [TBL] [Abstract][Full Text] [Related]
4. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. Weiss TW; Arnesen H; Seljeflot I Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy. Chen H; Zhang X; Liao N; Wen F Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232 [TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa. Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226 [TBL] [Abstract][Full Text] [Related]
7. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes. Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452 [TBL] [Abstract][Full Text] [Related]
8. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients. Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269 [TBL] [Abstract][Full Text] [Related]
9. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. Sherwin JR; Smith SK; Wilson A; Sharkey AM J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539 [TBL] [Abstract][Full Text] [Related]
10. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Robinson M; Gray SR; Watson MS; Kennedy G; Hill A; Belch JJ; Nimmo MA Scand J Med Sci Sports; 2010 Apr; 20(2):282-90. PubMed ID: 19422646 [TBL] [Abstract][Full Text] [Related]
11. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters? Kovacs E; Kuehn JJ Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687 [TBL] [Abstract][Full Text] [Related]
12. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling. Hashizume M; Mihara M Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases. Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364 [TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions. Opatrna S; Lysak D; Trefil L; Parker C; Topley N Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924 [TBL] [Abstract][Full Text] [Related]
16. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. Oelzner P; Franke S; Lehmann G; Eidner T; Hein G; Wolf G Rheumatol Int; 2012 Jan; 32(1):199-206. PubMed ID: 20821212 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum. Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390 [TBL] [Abstract][Full Text] [Related]
18. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance]. Li Y; Wang Y; Qi L Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537 [TBL] [Abstract][Full Text] [Related]
19. Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction. Kaminski KA; Kozuch M; Bonda T; Wojtkowska I; Kozieradzka A; Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Winnicka MM; Musial WJ Atherosclerosis; 2009 Oct; 206(2):581-7. PubMed ID: 19406401 [TBL] [Abstract][Full Text] [Related]
20. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19. Rodríguez-Hernández MÁ; Carneros D; Núñez-Núñez M; Coca R; Baena R; López-Ruiz GM; Cano-Serrano ME; Martínez-Tellería A; Fuentes-López A; Praena-Fernandez JM; Garbers C; Hernández-Quero J; García F; Rose-John S; Bustos M Front Immunol; 2022; 13():891456. PubMed ID: 35634332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]